662 related articles for article (PubMed ID: 17374389)
41. Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Dash AP; Tyagi BK
Bull World Health Organ; 2007 Feb; 85(2):138-45. PubMed ID: 17308735
[TBL] [Abstract][Full Text] [Related]
42. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.
Simonsen PE; Magesa SM; Meyrowitsch DW; Malecela-Lazaro MN; Rwegoshora RT; Jaoko WG; Michael E
Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):541-7. PubMed ID: 15869771
[TBL] [Abstract][Full Text] [Related]
43. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.
Ottesen EA; Vijayasekaran V; Kumaraswami V; Perumal Pillai SV; Sadanandam A; Frederick S; Prabhakar R; Tripathy SP
N Engl J Med; 1990 Apr; 322(16):1113-7. PubMed ID: 2181312
[TBL] [Abstract][Full Text] [Related]
44. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
[TBL] [Abstract][Full Text] [Related]
45. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
[TBL] [Abstract][Full Text] [Related]
46. Diethylcarbamazine in the control of bancroftian filariasis in the Ok Tedi area of Papua New Guinea: phase 2--annual single-dose treatment.
Schuurkamp GJ; Kereu RK; Bulungol PK; Kawereng A; Spicer PE
P N G Med J; 1994 Jun; 37(2):65-81. PubMed ID: 7771117
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
48. Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa.
Mladonicky JM; King JD; Liang JL; Chambers E; Pa'au M; Schmaedick MA; Burkot TR; Bradley M; Lammie PJ
Am J Trop Med Hyg; 2009 May; 80(5):769-73. PubMed ID: 19407122
[TBL] [Abstract][Full Text] [Related]
49. [Combinations of ivermectin and diethylcarbamazine for improved control of lymphatic filariasis].
Moulia-Pelat JP; Nguyen LN; Hascoet H; Nicolas L
Parasite; 1996 Mar; 3(1):45-8. PubMed ID: 8731761
[TBL] [Abstract][Full Text] [Related]
50. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
[TBL] [Abstract][Full Text] [Related]
51. Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Laman M; Tavul L; Karl S; Kotty B; Kerry Z; Kumai S; Samuel A; Lorry L; Timinao L; Howard SC; Makita L; John L; Bieb S; Wangi J; Albert JM; Payne M; Weil GJ; Tisch DJ; Bjerum CM; Robinson LJ; King CL
Lancet Infect Dis; 2022 Aug; 22(8):1200-1209. PubMed ID: 35533701
[TBL] [Abstract][Full Text] [Related]
52. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K; Stolk WA; Basáñez MG; Collyer BS; de Vlas SJ; Diggle PJ; Gass K; Graham M; Hollingsworth TD; King JD; Krentel A; Anderson RM; Coffeng LE
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S93-S100. PubMed ID: 38662701
[TBL] [Abstract][Full Text] [Related]
53. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
54. Filarial vector studies in a diethylcarbamazine-treated and in untreated villages in Papua New Guinea.
Bryan JH; Dagoro H; Southgate BA
J Trop Med Hyg; 1995 Dec; 98(6):445-51. PubMed ID: 8544229
[TBL] [Abstract][Full Text] [Related]
55. Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
Mayfield HJ; Sartorius B; Sheridan S; Howlett M; Martin BM; Thomsen R; Tofaeono-Pifeleti R; Viali S; Graves PM; Lau CL
PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012236. PubMed ID: 38935622
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Sankari T; Subramanian S; Hoti SL; Pani SP; Jambulingam P; Das PK
Parasitol Res; 2021 Jan; 120(1):311-319. PubMed ID: 33146778
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of mass single-dose diethylcarbamazine and DEC-fortified salt against bancroftian filariasis in Papua New Guinea six months after treatment.
Sapak P; Williams G; Bryan J; Riley I
P N G Med J; 2000; 43(3-4):213-20. PubMed ID: 11939303
[TBL] [Abstract][Full Text] [Related]
58. Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation.
Cartel JL; Spiegel A; Nguyen Ngnoc L; Cardines R; Plichart R; Martin PM; Roux JF; Moulia-Pelat JP
Trop Med Parasitol; 1992 Jun; 43(2):91-4. PubMed ID: 1519031
[TBL] [Abstract][Full Text] [Related]
59. Ultrastructural analysis of microfilariae of Wuchereria bancrofti obtained from persistent carriers after repeated courses of diethylcarbamazine.
Alves LC; Cavalcanti MG; Araújo HR; Silva GM; Veras DL; Paiva MH; Brayner FA
Micron; 2009; 40(5-6):659-64. PubMed ID: 19359187
[TBL] [Abstract][Full Text] [Related]
60. Modelling the epidemiology, transmission and control of lymphatic filariasis.
Das PK; Subramanian S
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
